PR
Healthcare & Life Sciences
Probiodrug
Germany
Probiodrug is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Probiodrug
Probiodrug is a company headquartered in Germany. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Probiodrug is a biotechnology company developing therapeutic agents for Alzheimer's disease by inhibiting glutaminyl cyclase to prevent the formation of pyroglutamate-modified amyloid-beta, with their lead program historically known as PQ912 or varoglutamstat.
Explore Probiodrug's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.